EDIT YTD ReturnEditas Medicine YTD Return




The EDIT YTD return is 20.00% with dividends reinvested through 05/19/2026. Investors often use YTD return to compare year-to-date performance across securities because current calendar year return information is important for tax planning.

This page shows EDIT YTD return, annualized return, start and end dates, and the growth of a hypothetical $10,000 investment with dividends reinvested.

Quick links: YTD Return Table  |  Performance Chart  |  Peers
Start date: 12/31/2025
End date: 05/19/2026
Start price/share: $2.05
End price/share: $2.46
Dividends collected/share: $0.00
EDIT YTD return: 20.00%
Annualized Gain: 52.90%
Starting investment: $10,000.00
Ending investment: $12,000.00
Years: 0.38


EDIT YTD return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare EDIT YTD return (see YTD Return Formula; YTD Return vs Yield) versus benchmarks:

YTD Return on S&P
YTD Return on Dow
YTD Return on Nasdaq 100
YTD Return on Russell 2000
YTD Return on Gold
YTD Return on 10 Year Treasury
YTD Return on $10,000.00
Without Dividends Reinvested Into EDIT


Also see: EDIT Average Annual Return
Editas Medicine, Inc. is a clinical-stage genome editing company. Co. is focused on developing potentially transformative genomic medicines to treat a broad range of serious diseases. It has developed a proprietary gene editing platform based on CRISPR technology. CRISPR uses a protein- ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 (Cas9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1), bound to a guide ribonucleic acid (RNA) molecule designed to recognize a particular deoxyribonucleic acid (DNA) sequence. The EDIT YTD return is shown above.

The YTD Return on the EDIT YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis.

Thus, researching Year-To-Date Returns is good practice for investors — whether EDIT YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the EDIT YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns.
Quotes delayed 20 minutes

Email EnvelopeFree EDIT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in YTD Return!
Editas Medicine (EDIT) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:

EGLT YTD Return
EGRX YTD Return
EHAB YTD Return
EHC YTD Return
EIDX YTD Return
EIGR YTD Return
EKSO YTD Return
ELAB YTD Return
ELAN YTD Return
ELDN YTD Return
More Healthcare companies »
 

EDIT YTD Return | www.YTDReturn.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in YTDReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.